Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 1 October 2027
- Last conf. stmt
- 17 September 2026
Glaxosmithkline Ihc Limited
- Incorporated
- 18 May 2010 (16 years)
- Industry
- Financial intermediation not elsewhere classified (64999)
- Owned by
- Accounts type
- Full
- Region
- Greater London
- Address
- 79 New Oxford StreetLondonWC1A 1DG
Officers 5 active
Officer details are public data from the Companies House register.
Director · Appointed 6 December 2023
British
Born January 1979 (47)
Director · Appointed 17 September 2020
British
Born December 1972 (53)
Director · Appointed 17 June 2015
British
Born November 1967
Whyte, Victoria Anne
Secretary · Appointed 18 May 2010
Edinburgh Pharmaceutical Industries Limited
Corporate Secretary · Appointed 18 May 2010
Officer history (9 former)
6 December 2023
6 December 2023
6 December 2023
Resigned Edinburgh Pharmaceutical Industries Limited as Corporate Director
9 November 2020
17 September 2020
2 March 2020
2 March 2020
3 April 2019
25 February 2019
13 February 2019
31 January 2017
1 March 2016
17 June 2015
14 December 2012
3 December 2012
20 October 2010
16 August 2010
18 May 2010
18 May 2010
18 May 2010
Appointed Edinburgh Pharmaceutical Industries Limited as Corporate Director
18 May 2010
Appointed Whyte, Victoria Anne as Secretary
18 May 2010
18 May 2010
Appointed Edinburgh Pharmaceutical Industries Limited as Corporate Secretary
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 242686
Group structure 22 shown
Ownership group derived from the Companies House PSC register
British Pharma Group Limited Holds 25–50% of voting rights
Glaxosmithkline Holdings (One) Limited Owns 75–100% of shares
Glaxosmithkline Holdings Limited Owns 75–100% of shares
Glaxosmithkline Finance PLC Owns 75–100% of shares
Glaxo Group Limited Owns 75–100% of shares
Glaxosmithkline Ihc Limited This company Owns 75–100% of shares
GSK Finance (No 2) Limited Owns 75–100% of shares
Setfirst Limited Owns 75–100% of shares
Smithkline Beecham Limited Owns 75–100% of shares
Wellcome Limited Owns 75–100% of shares
Glaxosmithkline Mercury Limited Owns 75–100% of shares
Viiv Healthcare Limited Owns 75–100% of shares
Viiv Healthcare Finance 2 Limited Owns 75–100% of shares
Viiv Healthcare Overseas Limited Owns 75–100% of shares
Viiv Healthcare Trading Services UK Limited Owns 75–100% of shares
Viiv Healthcare UK (No.4) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.5) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.6) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.7) Limited Owns 75–100% of shares
Viiv Healthcare UK Limited Owns 75–100% of shares
Glaxosmithkline Services Unlimited Owns 75–100% of shares
Filings 67
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 17 September 2026 | Confirmation statement with no updates | 17 September 2026 | ||
| 1 July 2026 | Full accounts | 31 December 2025 | ||
| 27 February 2026 | Director's details changed | |||
| 29 September 2025 | Confirmation statement with no updates | 29 September 2025 | ||
| 28 May 2025 | Full accounts | 31 December 2024 |
Some other companies at this address
Other companies in this industry
Manchester
Manchester
London
London
London
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →